Yamamoto, Shun
Sakakibara, Naoki
Hirano, Hidekazu
Morizane, Chigusa
Honma, Yoshitaka
Hijioka, Susumu
Okusaka, Takuji
Higashi, Takahiro
Kawai, Akira
Funding for this research was provided by:
National Cancer Center Japan (28-A-16, 31-A-14)
Article History
Received: 14 May 2022
Accepted: 18 October 2022
First Online: 20 October 2022
Change Date: 19 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-022-26509-z
Competing interests
: NS, HH, YH, TH, and AK have nothing to declare. SY has received honoraria from Ono Pharmaceutical. CM has received honoraria from Novartis Pharma and Teijin Pharma, FUJIFILM Toyama Chemical. SH has received honoraria from Novartis Pharma and Teijin Pharma, FUJIFILM Toyama Chemical. TO has received research funding from AstraZeneca and Eisai, Bristol-Myers Squibb, MSD.